Drug comparisons
Gliclazide vs Bexagliflozin
Gliclazide vs Bexagliflozin: Oral sulfonylurea vs SGLT2 inhibitor for T2D. Compare A1c, hypo risk, weight effects, CV/renal benefits, and infection risks.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing between a sulfonylurea and an SGLT2 inhibitor as oral therapy for type 2 diabetes, weighing extra benefits against distinct side-effect profiles.
Bottom line
Bexagliflozin often provides weight loss plus cardiovascular and renal benefits versus Gliclazide, but the sulfonylurea may suit those prioritizing low cost and insulin stimulation.
All medication comparisons